These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 16424527)
1. Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome. Aragona P; Di Pietro R; Spinella R; Mobrici M Br J Ophthalmol; 2006 Feb; 90(2):166-70. PubMed ID: 16424527 [TBL] [Abstract][Full Text] [Related]
2. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients. Aragona P; Bucolo C; Spinella R; Giuffrida S; Ferreri G Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4474-9. PubMed ID: 16303936 [TBL] [Abstract][Full Text] [Related]
3. Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with sjögren syndrome. Ibrahim OM; Dogru M; Kawashima S; Wakamatsu TH; Tsubota K; Fujishima H Cornea; 2013 May; 32(5):653-7. PubMed ID: 23146930 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study. Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277 [TBL] [Abstract][Full Text] [Related]
5. In vivo confocal microscopy of conjunctival goblet cells in patients with Sjogren's syndrome dry eye. Hong J; Zhu W; Zhuang H; Xu J; Sun X; Le Q; Li G; Wang Y Br J Ophthalmol; 2010 Nov; 94(11):1454-8. PubMed ID: 19955202 [TBL] [Abstract][Full Text] [Related]
6. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome. Demiryay E; Yaylali V; Cetin EN; Yildirim C Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057 [TBL] [Abstract][Full Text] [Related]
7. Conjunctival in vivo confocal scanning laser microscopy in patients with Sjögren syndrome. Wakamatsu TH; Sato EA; Matsumoto Y; Ibrahim OM; Dogru M; Kaido M; Ishida R; Tsubota K Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):144-50. PubMed ID: 19696170 [TBL] [Abstract][Full Text] [Related]
8. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome. Jorkjend L; Bergenholtz A; Johansson AK; Johansson A Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333 [TBL] [Abstract][Full Text] [Related]
9. A controlled release pilocarpine buccal insert in the treatment of Sjögren's syndrome. Gibson J; Halliday JA; Ewert K; Robertson S Br Dent J; 2007 Apr; 202(7):E17; discussion 404-5. PubMed ID: 17273177 [TBL] [Abstract][Full Text] [Related]
10. [Treatment with pilocarpine hydrochloride for sicca symptoms in Sjögren's syndrome]. Takaya M; Ichikawa Y; Yamada C; Hoshina Y; Horiki T; Uchiyama M Ryumachi; 1997 Jun; 37(3):453-7. PubMed ID: 9256028 [TBL] [Abstract][Full Text] [Related]
11. Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients. Aragona P; Stilo A; Ferreri F; Mobrici M Eye (Lond); 2005 May; 19(5):535-9. PubMed ID: 15184937 [TBL] [Abstract][Full Text] [Related]
12. Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study. Tsifetaki N; Kitsos G; Paschides CA; Alamanos Y; Eftaxias V; Voulgari PV; Psilas K; Drosos AA Ann Rheum Dis; 2003 Dec; 62(12):1204-7. PubMed ID: 14644860 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411 [TBL] [Abstract][Full Text] [Related]
14. Effects of immunosuppressive drugs on the morphology of the microvilli in Sjögren's syndrome. Scharf JM; Meyer E; Scharf JA; Nahir M; Zonis S Scand J Rheumatol Suppl; 1986; 61():215-9. PubMed ID: 3473634 [TBL] [Abstract][Full Text] [Related]
15. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome. Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228 [TBL] [Abstract][Full Text] [Related]
16. Qualitative tear film and conjunctival goblet cell assessment of cats with corneal sequestra. Grahn BH; Sisler S; Storey E Vet Ophthalmol; 2005; 8(3):167-70. PubMed ID: 15910369 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of tear function tests in Sjogren's syndrome patients. Versura P; Frigato M; Cellini M; Mulè R; Malavolta N; Campos EC Eye (Lond); 2007 Feb; 21(2):229-37. PubMed ID: 16397619 [TBL] [Abstract][Full Text] [Related]
19. Effect of sodium sucrose-sulfate on the ocular surface of patients with keratoconjunctivitis sicca in Sjögren's syndrome. Prause JU; Bjerrum K; Johansen S Adv Exp Med Biol; 1994; 350():691-6. PubMed ID: 8030557 [No Abstract] [Full Text] [Related]
20. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin. Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]